Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Differential Levels of mRNAs in Normal B Lymphocytes, Monoclonal B Lymphocytosis and Chronic Lymphocytic Leukemia Cells from the Same Family Identify Susceptibility Genes

Differential Levels of mRNAs in Normal B Lymphocytes, Monoclonal B Lymphocytosis and Chronic... IntroductionPeople with a family history of chronic lymphocytic leukemia (F-CLL) have an increased risk of monoclonal B lymphocytosis (F-MBL), which is found in up to 18% of first-degree relatives of patients compared to 5% of the total population. This may indicate that the presence of an F-MBL in the relative of a F-CLL patient is due to genetic susceptibility. In this study, we hypothesized that progressive changes in gene expression result in malignant transformation of B lymphocytes to F-MBL, and subsequent alterations in gene expression occur before overt F-CLL develops. The aim of this study of affected and unaffected individuals from a family with multiple CLL cases was to compare mRNA expression levels in control B-lymphocytes, pre-malignant F-MBL and malignant F-CLL cells.MethodsTo identify inherited changes in gene expression, a high-resolution DNA microarray was used to identify differentially abundant mRNAs in age-matched cases of F-MBL (n = 4), F-CLL (n = 2) and unaffected family relatives (F-Controls, n = 3) within one family. These were then compared to non-kindred controls (NK-Controls, n = 3) and sporadic CLL (S-CLL) cases (n = 6).ResultsSeven differentially abundant mRNAs were identified against similar genetic backgrounds of the family: GRASP and AC016745.3 were decreased in F-MBL and further decreased in F-CLL compared to F-Controls, whereas C11orf80 and METTL8 were progressively increased. PARP3 was increased in F-MBL compared to F-Controls but was decreased in F-CLL compared to F-MBL. Compared to F-Controls, levels of ROR1 and LEF1 were similarly increased in F-MBL and F-CLL. For six of the genes, there were no differences in mRNA levels between S-CLL and F-CLL; however PARP3 was higher in S-CLL.ConclusionThese results are consistent with the hypothesis that changes in expression of specific genes contribute to transformation from normal lymphocytes to MBL and CLL. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Differential Levels of mRNAs in Normal B Lymphocytes, Monoclonal B Lymphocytosis and Chronic Lymphocytic Leukemia Cells from the Same Family Identify Susceptibility Genes

Download PDF
14 pages

Loading next page...
 
/lp/springer-journals/differential-levels-of-mrnas-in-normal-b-lymphocytes-monoclonal-b-evULldhdSE
Publisher
Springer Journals
Copyright
Copyright © The Author(s) 2021
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-021-00172-2
Publisher site
See Article on Publisher Site

Abstract

IntroductionPeople with a family history of chronic lymphocytic leukemia (F-CLL) have an increased risk of monoclonal B lymphocytosis (F-MBL), which is found in up to 18% of first-degree relatives of patients compared to 5% of the total population. This may indicate that the presence of an F-MBL in the relative of a F-CLL patient is due to genetic susceptibility. In this study, we hypothesized that progressive changes in gene expression result in malignant transformation of B lymphocytes to F-MBL, and subsequent alterations in gene expression occur before overt F-CLL develops. The aim of this study of affected and unaffected individuals from a family with multiple CLL cases was to compare mRNA expression levels in control B-lymphocytes, pre-malignant F-MBL and malignant F-CLL cells.MethodsTo identify inherited changes in gene expression, a high-resolution DNA microarray was used to identify differentially abundant mRNAs in age-matched cases of F-MBL (n = 4), F-CLL (n = 2) and unaffected family relatives (F-Controls, n = 3) within one family. These were then compared to non-kindred controls (NK-Controls, n = 3) and sporadic CLL (S-CLL) cases (n = 6).ResultsSeven differentially abundant mRNAs were identified against similar genetic backgrounds of the family: GRASP and AC016745.3 were decreased in F-MBL and further decreased in F-CLL compared to F-Controls, whereas C11orf80 and METTL8 were progressively increased. PARP3 was increased in F-MBL compared to F-Controls but was decreased in F-CLL compared to F-MBL. Compared to F-Controls, levels of ROR1 and LEF1 were similarly increased in F-MBL and F-CLL. For six of the genes, there were no differences in mRNA levels between S-CLL and F-CLL; however PARP3 was higher in S-CLL.ConclusionThese results are consistent with the hypothesis that changes in expression of specific genes contribute to transformation from normal lymphocytes to MBL and CLL.

Journal

Oncology and Therapy – Springer Journals

Published: Dec 1, 2021

Keywords: Chronic lymphocytic leukemia; Familial; Gene expression; Monoclonal B lymphocytosis

References

  • Cancer statistics, 2018
    Siegel, RL; Miller, KD; Jemal, A
  • Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia
    Bevan, S; Catovsky, D; Matutes, E; Antunovic, P; Auger, MJ; Ben-Bassat, I
  • Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database
    Czene, K; Lichtenstein, P; Hemminki, K
  • Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients
    Rawstron, A; Hillmen, P; Houlston, R
  • Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion
    Rawstron, AC; Yuille, MR; Fuller, J; Cullen, M; Kennedy, B; Richards, SJ
  • A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
    Di Bernardo, MC; Crowther-Swanepoel, D; Broderick, P; Webb, E; Sellick, G; Wild, R
  • Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
    Crowther-Swanepoel, D; Broderick, P; Di Bernardo, MC; Dobbins, SE; Torres, M; Mansouri, M
  • A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
    Speedy, HE; Di Bernardo, MC; Sava, GP; Dyer, MJ; Holroyd, A; Wang, Y
  • Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
    Kleinstern, G; Camp, NJ; Goldin, LR; Vachon, CM; Vajdic, CM; de Sanjose, S
  • A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor
    Gazzoli, I; Loda, M; Garber, J; Syngal, S; Kolodner, RD
  • DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
    Esteller, M; Fraga, MF; Guo, M; Garcia-Foncillas, J; Hedenfalk, I; Godwin, AK
  • A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes
    McCarthy, BA; Yancopoulos, S; Tipping, M; Yan, XJ; Wang, XP; Bennett, F
  • Analysis of a large multi-generational family provides insight into the genetics of chronic lymphocytic leukemia
    Fuller, SJ; Papaemmanuil, E; McKinnon, L; Webb, E; Sellick, GS; Dao-Ung, LP
  • Genetic and genomic discovery using family studies
    Borecki, IB; Province, MA
  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
    Hallek, M; Cheson, BD; Catovsky, D; Caligaris-Cappio, F; Dighiero, G; Dohner, H
  • Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail
    Essakali, S; Carney, D; Westerman, D; Gambell, P; Seymour, JF; Dobrovic, A
  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936
    van Dongen, JJ; Langerak, AW; Bruggemann, M; Evans, PA; Hummel, M; Lavender, FL
  • Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936
    van Krieken, JH; Langerak, AW; Macintyre, EA; Kneba, M; Hodges, E; Sanz, RG
  • ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia
    Ghia, P; Stamatopoulos, K; Belessi, C; Moreno, C; Stilgenbauer, S; Stevenson, F
  • Quantitative real-time PCR eliminates false-positives in colony screening PCR
    Skarratt, KK; Fuller, SJ
  • Statistical analysis of real-time PCR data
    Yuan, JS; Reed, A; Chen, F; Stewart, CN
  • Estimation and control of multiple testing error rates for microarray studies
    Pounds, SB
  • Identifying differentially expressed genes using false discovery rate controlling procedures
    Reiner, A; Yekutieli, D; Benjamini, Y
  • Controlling the false discovery rate: a practical and powerful approach to multiple testing
    Benjamini, Y; Hochberg, Y
  • A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
    Binet, JL; Auquier, A; Dighiero, G; Chastang, C; Piguet, H; Goasguen, J
  • Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features
    Morabito, F; Mosca, L; Cutrona, G; Agnelli, L; Tuana, G; Ferracin, M
  • Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL
    Lanasa, MC; Allgood, SD; Slager, SL; Dave, SS; Love, C; Marti, GE
  • Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
    Law, PJ; Sud, A; Mitchell, JS; Henrion, M; Orlando, G; Lenive, O
  • Chronic lymphocytic leukemia in young (
    Parikh, SA; Rabe, KG; Kay, NE; Call, TG; Ding, W; Schwager, SM
  • High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid
    Wu, W; Zhu, H; Fu, Y; Shen, W; Miao, K; Hong, M
  • LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
    Gutierrez, A; Tschumper, RC; Wu, X; Shanafelt, TD; Eckel-Passow, J; Huddleston, PM
  • Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice
    van Genderen, C; Okamura, RM; Farinas, I; Quo, RG; Parslow, TG; Bruhn, L
  • Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia
    Baskar, S; Kwong, KY; Hofer, T; Levy, JM; Kennedy, MG; Lee, E
  • Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia
    Palermo, G; Maisel, D; Barrett, M; Smith, H; Duchateau-Nguyen, G; Nguyen, T
  • Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β
    Douglas, RS; Capocasale, RJ; Lamb, RJ; Nowell, PC; Moore, JS
  • The TGF-beta - SMAD pathway is inactivated in cronic lymphocytic leukemia cells
    Matveeva, A; Kovalevska, L; Kholodnyuk, I; Ivanivskaya, T; Kashuba, E
  • Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism
    Reya, T; O'Riordan, M; Okamura, R; Devaney, E; Willert, K; Nusse, R
  • Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo
    Gandhirajan, RK; Staib, PA; Minke, K; Gehrke, I; Plickert, G; Schlosser, A
  • Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
    Daneshmanesh, AH; Mikaelsson, E; Jeddi-Tehrani, M; Bayat, AA; Ghods, R; Ostadkarampour, M
  • Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
    Yu, J; Chen, L; Cui, B; Widhopf, GF; Shen, Z; Wu, R
  • Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
    Choudhury, A; Derkow, K; Daneshmanesh, AH; Mikaelsson, E; Kiaii, S; Kokhaei, P
  • Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia
    Aghebati-Maleki, L; Shabani, M; Baradaran, B; Motallebnezhad, M; Majidi, J; Yousefi, M
  • Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression
    Boehler, C; Gauthier, LR; Mortusewicz, O; Biard, DS; Saliou, JM; Bresson, A
  • The PARP inhibitor AZD2461 provides insights into the role of PARP3 inhibition for both synthetic lethality and tolerability with chemotherapy in preclinical models
    Oplustil O'Connor, L; Rulten, SL; Cranston, AN; Odedra, R; Brown, H; Jaspers, JE
  • GRASP and IPCEF promote ARF-to-Rac signaling and cell migration by coordinating the association of ARNO/cytohesin 2 with Dock180
    White, DT; McShea, KM; Attar, MA; Santy, LC
  • The scaffolding protein GRASP/Tamalin directly binds to Dock180 as well as to cytohesins facilitating GTPase crosstalk in epithelial cell migration
    Attar, MA; Santy, LC
  • Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens
    Liao, W; Jordaan, G; Nham, P; Phan, RT; Pelegrini, M; Sharma, S
  • Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis
    Chadeau-Hyam, M; Vermeulen, RC; Hebels, DG; Castagne, R; Campanella, G; Portengen, L
  • CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC
    Perez-Chacon, G; Vargas, JA; Jorda, J; Morado, M; Rosado, S; Martin-Donaire, T
  • Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future
    Brown, JR